PLMR compared with PTCT: revenue, margins and what each company keeps, and the suppliers and customers both name

PLMRPalomar Holdings, Inc.

Mkt capRevenueRevenue

PTCTPTC Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

PLMRPalomar Holdings, Inc.

PTCTPTC Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

PLMR

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±8.3%▼−1.55%×0.19

Q1 FY26±8.4%▲+2.55%×0.30

Feb 12 '26±7.1%▼−3.52%×0.49

Nov 7 '25±7.9%▲+8.72%×1.10

PTCT

1 of 4at or beyond implied

Reportimpliedrealized× implied

Oct 30 '26±12.0%▼−6.97%×0.58

Q2 FY26±11.6%▼−9.94%×0.85

= impliedPLMR realized, solidPTCT realized, hatchedOne scale, both sides: full bar = 15%× = |realized| ÷ impliedSource: market data

Q1 FY26

±9.4%

▲+14.27%

×1.52

Feb 20 '26±4.3%▲+1.09%×0.26

PLMRPalomar Holdings, Inc.

145.34· pre 145.34· delayed

Mkt cap$3.8BRevenue$309MQ2 FY26Revenue$876MFY25

PTCTPTC Therapeutics, Inc.

60.97· pre 63.31· delayed

Pre-marketNov 3 '26delayed

Mkt cap$5.0BRevenue$361MQ2 FY26Revenue$1.7BFY25

Compare

Pre-marketNov 3 '26delayed

PLMRPalomar Holdings, Inc.

PTCTPTC Therapeutics, Inc.

145.34pre 145.34delayed

Price

60.97pre 63.31delayed

$3.8B

Mkt cap

$5.0B

Q2 FY26$309M

Revenue

$361MQ2 FY26

FY25$876M

Revenue

$1.7BFY25

PLMR145.34vsPTCT60.97Pre-marketNov 3 '26delayed